AAPL348.51-2.18 (-0.62%) ▼|ABBV293.89+0.59 (+0.20%) ▲|ABT110.46-0.05 (-0.05%) ▼|ACN258.51+4.14 (+1.63%) ▲|ADBE236.70-0.62 (-0.26%) ▼|AMAT372.53+1.98 (+0.53%) ▲|AMD515.21+6.63 (+1.30%) ▲|AMGN465.23+0.00 (+0.00%) ▲|AMT190.37+1.37 (+0.72%) ▲|AMZN270.87+3.94 (+1.48%) ▲|AVGO331.98+12.50 (+3.91%) ▲|AXP323.46-0.85 (-0.26%) ▼|BA173.38+1.00 (+0.58%) ▲|BAC50.68+0.13 (+0.26%) ▲|BKNG159.26-4.23 (-2.59%) ▼|BLK1,222.15+7.44 (+0.61%) ▲|BMY62.80+0.66 (+1.06%) ▲|BNY151.14-0.09 (-0.06%) ▼|BRK-B583.34+8.09 (+1.41%) ▲|C122.27+0.30 (+0.25%) ▲|CAT584.57-14.31 (-2.39%) ▼|CL98.09+0.15 (+0.15%) ▲|CMCSA24.75+0.24 (+0.98%) ▲|COF195.84-2.74 (-1.38%) ▼|COP135.59+1.12 (+0.83%) ▲|COST1,066.14-0.04 (0.00%) ▼|CRM213.48-1.46 (-0.68%) ▼|CSCO98.15-0.50 (-0.51%) ▼|CVS89.01+3.76 (+4.41%) ▲|CVX211.22+0.44 (+0.21%) ▲|DE687.64-3.64 (-0.53%) ▼|DHR236.11+0.99 (+0.42%) ▲|DIS119.21+0.09 (+0.08%) ▲|DUK128.94+0.84 (+0.66%) ▲|EMR167.54-1.98 (-1.17%) ▼|FDX319.48+0.64 (+0.20%) ▲|GD367.44+5.37 (+1.48%) ▲|GE337.91+2.37 (+0.71%) ▲|GEV797.04-32.30 (-3.89%) ▼|GILD170.87+1.55 (+0.92%) ▲|GM88.69-0.96 (-1.07%) ▼|GOOG284.92-1.09 (-0.38%) ▼|GOOGL287.38-0.77 (-0.27%) ▼|GS910.19+3.97 (+0.44%) ▲|HD351.00-2.42 (-0.68%) ▼|HON228.22-0.78 (-0.34%) ▼|IBM244.53+0.11 (+0.05%) ▲|INTC58.13-1.24 (-2.09%) ▼|INTU340.44+2.21 (+0.65%) ▲|ISRG450.04-10.52 (-2.28%) ▼|JNJ280.78-1.33 (-0.47%) ▼|JPM342.07-0.01 (0.00%) ▼|KO96.91+0.88 (+0.92%) ▲|LIN521.78+1.45 (+0.28%) ▲|LLY1,432.29+20.34 (+1.44%) ▲|LMT603.12+14.93 (+2.54%) ▲|LOW231.87-0.23 (-0.10%) ▼|LRCX222.39+1.08 (+0.49%) ▲|MA658.84+3.03 (+0.46%) ▲|MCD282.17+0.73 (+0.26%) ▲|MDLZ66.54+0.10 (+0.15%) ▲|MDT101.59-1.20 (-1.17%) ▼|META641.39+0.02 (+0.00%) ▲|MMM189.37+0.74 (+0.39%) ▲|MO76.34+0.53 (+0.70%) ▲|MRK148.05-0.71 (-0.48%) ▼|MS187.56+0.46 (+0.25%) ▲|MSFT533.16-12.02 (-2.20%) ▼|MU725.11-8.04 (-1.10%) ▼|NEE86.27-0.59 (-0.68%) ▼|NFLX63.26-0.69 (-1.08%) ▼|NKE38.67-1.21 (-3.03%) ▼|NOW99.61-3.15 (-3.07%) ▼|NVDA168.89-9.78 (-5.47%) ▼|ORCL117.98-1.81 (-1.51%) ▼|PEP143.61+1.73 (+1.22%) ▲|PFE29.36+0.13 (+0.44%) ▲|PG168.66+0.34 (+0.20%) ▲|PLTR168.82-0.38 (-0.22%) ▼|PM194.25+1.13 (+0.59%) ▲|QCOM173.53+2.06 (+1.20%) ▲|RTX200.27+3.96 (+2.02%) ▲|SBUX109.95+0.51 (+0.47%) ▲|SCHW93.03+0.30 (+0.32%) ▲|SO93.65+0.08 (+0.09%) ▲|SPG234.48+1.47 (+0.63%) ▲|T21.94+0.14 (+0.64%) ▲|TMO718.20-3.43 (-0.48%) ▼|TMUS169.08+0.37 (+0.22%) ▲|TSLA379.78+1.73 (+0.46%) ▲|TXN300.52+4.79 (+1.62%) ▲|UBER70.05-1.12 (-1.57%) ▼|UNH405.12+7.50 (+1.89%) ▲|UNP300.62+3.61 (+1.22%) ▲|UPS111.05+0.09 (+0.08%) ▲|USB60.75-0.20 (-0.33%) ▼|V423.00+1.62 (+0.38%) ▲|VZ46.31+0.25 (+0.54%) ▲|WFC85.76+0.27 (+0.32%) ▲|WMT125.55-0.11 (-0.09%) ▼|XOM164.47-0.26 (-0.16%) ▼|AAPL348.51-2.18 (-0.62%) ▼|ABBV293.89+0.59 (+0.20%) ▲|ABT110.46-0.05 (-0.05%) ▼|ACN258.51+4.14 (+1.63%) ▲|ADBE236.70-0.62 (-0.26%) ▼|AMAT372.53+1.98 (+0.53%) ▲|AMD515.21+6.63 (+1.30%) ▲|AMGN465.23+0.00 (+0.00%) ▲|AMT190.37+1.37 (+0.72%) ▲|AMZN270.87+3.94 (+1.48%) ▲|AVGO331.98+12.50 (+3.91%) ▲|AXP323.46-0.85 (-0.26%) ▼|BA173.38+1.00 (+0.58%) ▲|BAC50.68+0.13 (+0.26%) ▲|BKNG159.26-4.23 (-2.59%) ▼|BLK1,222.15+7.44 (+0.61%) ▲|BMY62.80+0.66 (+1.06%) ▲|BNY151.14-0.09 (-0.06%) ▼|BRK-B583.34+8.09 (+1.41%) ▲|C122.27+0.30 (+0.25%) ▲|CAT584.57-14.31 (-2.39%) ▼|CL98.09+0.15 (+0.15%) ▲|CMCSA24.75+0.24 (+0.98%) ▲|COF195.84-2.74 (-1.38%) ▼|COP135.59+1.12 (+0.83%) ▲|COST1,066.14-0.04 (0.00%) ▼|CRM213.48-1.46 (-0.68%) ▼|CSCO98.15-0.50 (-0.51%) ▼|CVS89.01+3.76 (+4.41%) ▲|CVX211.22+0.44 (+0.21%) ▲|DE687.64-3.64 (-0.53%) ▼|DHR236.11+0.99 (+0.42%) ▲|DIS119.21+0.09 (+0.08%) ▲|DUK128.94+0.84 (+0.66%) ▲|EMR167.54-1.98 (-1.17%) ▼|FDX319.48+0.64 (+0.20%) ▲|GD367.44+5.37 (+1.48%) ▲|GE337.91+2.37 (+0.71%) ▲|GEV797.04-32.30 (-3.89%) ▼|GILD170.87+1.55 (+0.92%) ▲|GM88.69-0.96 (-1.07%) ▼|GOOG284.92-1.09 (-0.38%) ▼|GOOGL287.38-0.77 (-0.27%) ▼|GS910.19+3.97 (+0.44%) ▲|HD351.00-2.42 (-0.68%) ▼|HON228.22-0.78 (-0.34%) ▼|IBM244.53+0.11 (+0.05%) ▲|INTC58.13-1.24 (-2.09%) ▼|INTU340.44+2.21 (+0.65%) ▲|ISRG450.04-10.52 (-2.28%) ▼|JNJ280.78-1.33 (-0.47%) ▼|JPM342.07-0.01 (0.00%) ▼|KO96.91+0.88 (+0.92%) ▲|LIN521.78+1.45 (+0.28%) ▲|LLY1,432.29+20.34 (+1.44%) ▲|LMT603.12+14.93 (+2.54%) ▲|LOW231.87-0.23 (-0.10%) ▼|LRCX222.39+1.08 (+0.49%) ▲|MA658.84+3.03 (+0.46%) ▲|MCD282.17+0.73 (+0.26%) ▲|MDLZ66.54+0.10 (+0.15%) ▲|MDT101.59-1.20 (-1.17%) ▼|META641.39+0.02 (+0.00%) ▲|MMM189.37+0.74 (+0.39%) ▲|MO76.34+0.53 (+0.70%) ▲|MRK148.05-0.71 (-0.48%) ▼|MS187.56+0.46 (+0.25%) ▲|MSFT533.16-12.02 (-2.20%) ▼|MU725.11-8.04 (-1.10%) ▼|NEE86.27-0.59 (-0.68%) ▼|NFLX63.26-0.69 (-1.08%) ▼|NKE38.67-1.21 (-3.03%) ▼|NOW99.61-3.15 (-3.07%) ▼|NVDA168.89-9.78 (-5.47%) ▼|ORCL117.98-1.81 (-1.51%) ▼|PEP143.61+1.73 (+1.22%) ▲|PFE29.36+0.13 (+0.44%) ▲|PG168.66+0.34 (+0.20%) ▲|PLTR168.82-0.38 (-0.22%) ▼|PM194.25+1.13 (+0.59%) ▲|QCOM173.53+2.06 (+1.20%) ▲|RTX200.27+3.96 (+2.02%) ▲|SBUX109.95+0.51 (+0.47%) ▲|SCHW93.03+0.30 (+0.32%) ▲|SO93.65+0.08 (+0.09%) ▲|SPG234.48+1.47 (+0.63%) ▲|T21.94+0.14 (+0.64%) ▲|TMO718.20-3.43 (-0.48%) ▼|TMUS169.08+0.37 (+0.22%) ▲|TSLA379.78+1.73 (+0.46%) ▲|TXN300.52+4.79 (+1.62%) ▲|UBER70.05-1.12 (-1.57%) ▼|UNH405.12+7.50 (+1.89%) ▲|UNP300.62+3.61 (+1.22%) ▲|UPS111.05+0.09 (+0.08%) ▲|USB60.75-0.20 (-0.33%) ▼|V423.00+1.62 (+0.38%) ▲|VZ46.31+0.25 (+0.54%) ▲|WFC85.76+0.27 (+0.32%) ▲|WMT125.55-0.11 (-0.09%) ▼|XOM164.47-0.26 (-0.16%) ▼|
13 C
New York
Wednesday, November 11, 2026

Tag: health

newsFORsourcecompanycontentinformationreleases1IT

Johnson Fistel, PLLP Alerts Shareholders of Fortrea Holdings, Red Cat Holdings, Elevance Health, and West Pharmaceutical Services to Upcoming Class Action Lead Plaintiff Deadlines

SAN DIEGO, June 09, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a shareholder rights law firm, is alerting investors that class action lawsuits have been filed on behalf of purchasers of securities in Fortrea Holdings Inc. (NASDAQ: FTRE), Red Cat Holdings, Inc. (NASDAQ: RCAT), Elevance Health, Inc. (NYSE: ELV), and West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders are encouraged to review the information below and take action before the relevant deadlines.

Discovery Suggests Method to Offset Antibiotic-Caused Harm to Infant Immune Systems

In mice, inosine supplement restored normal T cell development and enhanced infection resistance, according to study published in Cell. CINCINNATI, June 9, 2025 /PRNewswire/ --...

Nature’s Sunshine Renews Scholarship Fund with Eccles School of Business

LEHI, Utah, June 09, 2025 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nasdaq: NATR), a leading natural health and wellness company that manufactures high quality herbal and nutritional products, announced the renewal of its scholarship in partnership with the David Eccles School of Business at the University of Utah to support economically disadvantaged students in their education.

Washington County, NY Sheriff’s Office First in the Nation to Provide Sheriff Rx™

Prescription Discount Program for County Employees in Partnership with BI2 Technologies, LLC FORT EDWARD, N.Y., June 9, 2025 /PRNewswire/ -- Washington County New York Sheriff...

Best Silica Litter for Cats (2025): Expert Consumers Publishes New Report on Leading Silica-Based Litter Solutions

As more cat owners seek smart, low-maintenance litter solutions, silica gel litters are standing out as a preferred choice across the pet care market. 
As more cat owners seek smart, low-maintenance litter solutions, silica gel litters are standing out as a preferred choice across the pet care market.

EQT Life Sciences Leads USD 80 Million Series A Funding Round in Mosanna Therapeutics to Advance Sleep Apnea Nasal Spray

Series A Funding will be used to advance Mosanna's nasal spray therapy through Phase 2 Clinical TrialsBiotech veteran David Weber has been appointed CEO...

Hydration Room Opens New IV Therapy Clinic in Porter Ranch, Launches Industry-First NAD+ IV Membership

PORTER RANCH, Calif., June 9, 2025 /PRNewswire/ -- Hydration Room, a doctor-founded leader in IV therapy and preventative wellness, has officially opened the doors...

Questex Receives Industry Recognition for its Impactful Content and Innovative Data-Driven Marketing Solutions

Won Prestigious Awards from the Jesse H. Neal Awards, the American Society of Business Publication Editors, National Institute for Health Care Management (NIHCM), NIHCM Foundation and Omeda OX8 
Won Prestigious Awards from the Jesse H. Neal Awards, the American Society of Business Publication Editors, National Institute for Health Care Management (NIHCM), NIHCM Foundation and Omeda OX8

New medial stabilized insert for Smith+Nephew’s LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatility

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of a new medial stabilized insert for its LEGION Total Knee System (TKS). Medial stabilized inserts are seeing a steep rise in popularity, growing from 4% of Total Knee Arthroplasty procedures in 2018 to 32% in 2023.1

tcmc to Showcase Asia’s Leading Cell & Gene Therapy CDMO Capabilities at BIO International Convention

BOSTON, June 9, 2025 /PRNewswire/ -- Taiwan Cell Manufacturing Company (tcmc), a leading Contract Development and Manufacturing Organization (CDMO) in cell and gene therapy...

Micron Biomedical Names Health Education and Empowerment Advocate, Dr. Jayne Morgan, to Board of Advisors

Dr. Jayne Morgan joins Micron Biomedical's Board of Advisors to promote public education on vaccines and therapeutics delivered without needles.

Superior Health Quality Alliance Selected by the Centers for Medicare & Medicaid Services (CMS) as Quality Innovation Network Quality Improvement Organization (QIN-QIO), Now Serving...

Superior Health Now Supports Medicare Providers Across 14 States and Two Territories  MADISON, Wis., June 9, 2025 /PRNewswire/ -- Superior Health Quality Alliance (Superior Health) is...

No Backyard? No Problem! President’s Choice® Brings Bookable Backyards to Toronto and Vancouver This Summer

One Backyard. Six Friends. Countless Summer Moments. BRAMPTON, ON, June 9, 2025 /CNW/ - As summer heats up, President's Choice® is partnering with...

Mosanna Therapeutics Launches with $80 Million to Advance Novel Nighttime Nasal Spray for Obstructive Sleep Apnea

Series A funding to advance MOS118 through Phase 2 clinical trials Biotech veteran David Weber appointed CEO to drive clinical development Obstructive sleep apnea affects nearly...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsHealth

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers